Filtered By:
Specialty: Cardiology
Infectious Disease: COVID-19
Drug: Aspirin

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

Antithrombotic Therapy Not Warranted in COVID-19 Outpatients Antithrombotic Therapy Not Warranted in COVID-19 Outpatients
In stable patients with COVID-19, use of aspirin or apixaban did not reduce the rate of the composite of all-cause mortality, thromboembolism, MI, stroke, or hospitalization in the ACTIV-4B trial.Medscape Medical News
Source: Medscape Cardiology Headlines - October 20, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Progress in aorta and peripheral cardiovascular disease research
AbstractAlthough coronavirus disease 2019 seems to be the leading topic in research number of outstanding studies have been published in the field of aorta and peripheral vascular diseases likely affecting our clinical practice in the near future. This review article highlights key research on vascular diseases published in 2020. Some studies have shed light in the pathophysiology of aortic aneurysm and dissection suggesting a potential role for kinase inhibitors as new therapeutic options. A first proteogenomic study on fibromuscular dysplasia (FMD) revealed a promising novel disease gene and provided proof-of-concept for...
Source: Cardiovascular Research - April 23, 2021 Category: Cardiology Source Type: research